NDC 63539-336

CIBINQO

Abrocitinib

CIBINQO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by U.s. Pharmaceuticals. The primary component is Abrocitinib.

Product ID63539-336_e12a1371-0adf-4237-a624-1bc713f5247c
NDC63539-336
Product TypeHuman Prescription Drug
Proprietary NameCIBINQO
Generic NameAbrocitinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2022-02-24
Marketing CategoryNDA /
Application NumberNDA213871
Labeler NameU.S. Pharmaceuticals
Substance NameABROCITINIB
Active Ingredient Strength100 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63539-336-14

14 TABLET, FILM COATED in 1 BOTTLE (63539-336-14)
Marketing Start Date2022-02-24
NDC Exclude FlagN
Sample Package?Y

Drug Details

NDC Crossover Matching brand name "CIBINQO" or generic name "Abrocitinib"

NDCBrand NameGeneric Name
0069-0235Cibinqoabrocitinib
0069-0335Cibinqoabrocitinib
0069-0435Cibinqoabrocitinib
63539-236CIBINQOabrocitinib
63539-336CIBINQOabrocitinib
63539-436CIBINQOabrocitinib

Trademark Results [CIBINQO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CIBINQO
CIBINQO
88592307 not registered Live/Pending
Pfizer Inc.
2019-08-26
CIBINQO
CIBINQO
86966113 not registered Live/Pending
Pfizer Inc.
2016-04-06
CIBINQO
CIBINQO
77733616 3797291 Dead/Cancelled
Pfizer Inc.
2009-05-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.